Advanced search
Publication Cover
Journal of Chemotherapy Volume 28, 2016 - Issue 4
Submit an article Journal homepage
155
Views
8
CrossRef citations to date
0
Altmetric
Anticancer Original Research Papers

Risk of gastrointestinal perforation in cancer patients receiving ramucirumab: a meta-analysis of randomized controlled trials

Zexing Wang1 Department of Oncology, Wuhu No. 2 People's Hospital Affiliated to Wannan Medical College, Anhui Province, China
,
Jun Zhang1 Department of Oncology, Wuhu No. 2 People's Hospital Affiliated to Wannan Medical College, Anhui Province, China
,
Liang Zhang2 Department of Urology and Institute of Prostatic Diseases, Wuhu No. 2 People's Hospital Affiliated to Wannan Medical College, Anhui Province, China
,
Pengying Liu1 Department of Oncology, Wuhu No. 2 People's Hospital Affiliated to Wannan Medical College, Anhui Province, China
,
Yamin Xie1 Department of Oncology, Wuhu No. 2 People's Hospital Affiliated to Wannan Medical College, Anhui Province, China
&
Qin Zhou1 Department of Oncology, Wuhu No. 2 People's Hospital Affiliated to Wannan Medical College, Anhui Province, ChinaCorrespondence[email protected]
Pages 328-334 | Received 07 Mar 2015, Accepted 26 May 2015, Published online: 27 Jul 2016

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Manuel Cobo, Vanesa Gutiérrez, Rosa Villatoro, Jose Manuel Trigo, Inmaculada Ramos, Omar López, María Ruiz, Ana Godoy, Irene López & Macarena Arroyo. (2017) Spotlight on ramucirumab in the treatment of nonsmall cell lung cancer: design, development, and clinical activity. Lung Cancer: Targets and Therapy 8, pages 57-66.
Read now
Anne Steins, Eva A. Ebbing, Marcel C. M. Pistorius, Cynthia Waasdorp, Kausilia K. Krishnadath, Jan Paul Medema, Johanna W. Wilmink, Ron A. A. Mathôt, Maarten F. Bijlsma & Hanneke W. M. van Laarhoven. (2017) Systemic effects of angiogenesis inhibition alter pharmacokinetics and intratumoral delivery of nab-paclitaxel. Drug Delivery 24:1, pages 1801-1810.
Read now

Articles from other publishers (6)

Hiroki Fukuya, Yoichiro Iboshi, Masafumi Wada, Yorinobu Sumida, Naohiko Harada, Makoto Nakamuta, Hiroyuki Fujii & Eikichi Ihara. (2023) Gastric cancer presenting with ramucirumab-related gastrocolic fistula successfully managed by colonic stenting: a case report. Clinical Endoscopy 56:6, pages 812-816.
Crossref
Robert H. Roth, Madison J. Malfitano, Matthew Reilley & Linda W. Martin. (2023) Delayed esophageal anastomotic complication and ramucirumab therapy: A case report. Thoracic Cancer 14:29, pages 2976-2980.
Crossref
Zicheng Yu, Haibin Zhu, Hongjun Chen, Lifei Zhu & Xiaolan Liao. (2023) Gastrointestinal perforation associated with novel antineoplastic agents: A real-world study based on the FDA Adverse Event Reporting System. Journal of Pharmacy & Pharmaceutical Sciences 26.
Crossref
Hongqiong Yang, Yaojun Zhou, Liangzhi Wang, Tianyi Gu, Mengjia Lv, Jinling Sun, Chao Tu & Junbo He. (2021) The Efficacy of Ramucirumab in the Treatment of Gastric or Gastroesophageal Junction Cancer: A Meta-Analysis of RCTs. Gastroenterology Research and Practice 2021, pages 1-8.
Crossref
Kohei Horioka, Takaaki Fujimoto, Mitsuhiro Nakamoto, Masumi Yamauchi, Toshitatsu Ogino, Hiroshi Nakashima, Kotaro Kitahara, Kenji Nakamura, Yasutaka Hachiya & Tokihiko Fukuyama. (2018) Esophagopericardial Fistula Formation during Chemotherapy for Unresectable Remnant Gastric Cancer Patient with Esophageal Stent食道ステント留置下に化学療法施行中の切除不能残胃癌の患者に発症した食道心囊瘻の1例. The Japanese Journal of Gastroenterological Surgery 51:8, pages 512-519.
Crossref
David Reeves. 2017. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions 465 482 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.